Tumor Test Marker YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 is an essential diagnostic tool designed to detect up to 18 different tumor markers using chemiluminescence immunoassay (CLIA) analyzers. This kit is instrumental for early cancer detection as it identifies elevated levels of tumor markers in the blood, assisting in the diagnosis and recognition of various malignant tumors. With its innovative technology, healthcare professionals can rely on precise and actionable results, making it a valuable addition to any medical practice.

Market Price

The market price for tumor marker test kits like the Tumor Test Marker YRA385 // YRA391 typically ranges from $60 to $240. This pricing reflects the advanced technology and comprehensive detection capabilities of the product. To obtain a specific quote or to generate an automatic quote, we encourage you to use our Kalstein Plus platform for personalized pricing details.

Frequently Asked Questions

What tumor markers can this kit detect? The kit detects markers such as AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA, among others.

How does chemiluminescence immunoassay work? CLIA is a technique that uses chemiluminescent signals to measure the presence and concentration of molecules, offering high sensitivity and specificity.

Is the kit easy to store? Yes, the kit is stored between 2-8°C, making it suitable for standard laboratory environments.

Advantages and Disadvantages

The Tumor Test Marker YRA385 // YRA391 offers several advantages, including high accuracy, the ability to detect multiple tumor markers, and compatibility with existing CLIA systems. However, the kit requires a controlled storage environment and might require initial setup calibration, which could be a consideration for some laboratories.

Product Use in the Field

In practical settings, the Tumor Test Marker YRA385 // YRA391 is used in clinical laboratories to test patient blood samples for tumor markers. This is particularly important for routine cancer screenings and monitoring the progression or treatment response in cancer patients.

Recommendations

To ensure optimal performance, it is recommended to regularly calibrate the equipment using the 2/6 point calibration system. Additionally, ensure the kit is stored properly and handled with care to maintain its efficacy. For any questions or to learn more about maximizing the kit’s capabilities, reach out to our expert support team.

Features

• Detects 18 different tumor markers
• Uses chemiluminescence immunoassay (CLIA) technology
• Stable storage conditions (2-8°C)
• Available in packages of 50T/BOX, 100T/BOX, and 24T/BOX

Technical Specifications